Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene Inactivation von Silence, J, Lupu, F, Collen, D, Lijnen, H R

Volltext

Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene von Silence, J, Collen, D, Lijnen, H R

Volltext

Stromelysin-1 (MMP-3)–Independent Gelatinase Expression and Activation in Mice von Lijnen, H.R., Silence, J., Van Hoef, B., Collen, D.

Volltext

Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice von LIJNEN, H. R, SILENCE, J, VAN HOEF, B, COLLEN, D

Volltext

Reduced athrosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene von J Silence, D Collen, Lijnen, H R

Volltext

Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene von Silence, J, Collen, Desire, Lijnen, Roger

Volltext

Students Can Become More Effective Readers von Silence, Mary Jane

Volltext

CD70: An emerging target in cancer immunotherapy von Jacobs, J, Deschoolmeester, V, Zwaenepoel, K, Rolfo, C, Silence, K, Rottey, S, Lardon, F, Smits, E, Pauwels, P

Volltext

1062 Amivantamab-induced pityriasis amiantacea von Rao, M., Pollock, S., Silence, C., Boetes, J., Kourosh, A.S.

Volltext

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome von HULSTEIN, J. J. J., VAN RUNNARD HEIMEL, P. J., FRANX, A., LENTING, P. J., BRUINSE, H. W., SILENCE, K., DE GROOT, PH. G., FIJNHEER, R.

Volltext

Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK von Lim, Jamie L., Augustinus, Roy, Plomp, Jaap J., Roya-Kouchaki, Kasra, Vergoossen, Dana L. E., Fillié-Grijpma, Yvonne, Struijk, Josephine, Thomas, Rachel, Salvatori, Daniela, Steyaert, Christophe, Blanchetot, Christophe, Vanhauwaert, Roeland, Silence, Karen, van der Maarel, Silvère M., Verschuuren, Jan J., Huijbers, Maartje G.

Volltext

Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma von Leupin, Nicolas, Zinzani, Pier Luigi, Morschhauser, Franck, Dalle, Stéphane, Maerevoet, Marie, Michot, Jean‐Marie, Ribrag, Vincent, Offner, Fritz, Beylot‐Barry, Marie, Moins‐Teisserenc, Hélène, Zwaenepoel, Karen, Winne, Koen, Battistella, Maxime, Hultberg, Anna, Gandini, Domenica, Moshir, Mahan, Jacobs, Julie, Delahaye, Tim, Khan, Aitzaz, Zabrocki, Piotr, Silence, Karen, Rompaey, Luc, Borg, Christophe, Motta, Giovanna, Melle, Federica, Calleri, Angelica, Pauwels, Patrick, Haard, Hans, Pileri, Stefano, Bagot, Martine

Volltext

Agonist antibody to MuSK protects mice from MuSK myasthenia gravis von Oury, Julien, Gamallo-Lana, Begona, Santana, Leah, Steyaert, Christophe, Vergoossen, Dana L E, Mar, Adam C, Vankerckhoven, Bernhardt, Silence, Karen, Vanhauwaert, Roeland, Huijbers, Maartje G, Burden, Steven J

Volltext

ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade von Silence, Karen, Dreier, Torsten, Moshir, Mahan, Ulrichts, Peter, Gabriels, Sofie ME, Saunders, Michael, Wajant, Harald, Brouckaert, Peter, Huyghe, Leander, Van Hauwermeiren, Tim, Thibault, Alain, De Haard, Hans J

Volltext

ARGX-117, a therapeutic complement inhibiting antibody targeting C2 von Van de Walle, Inge, Silence, Karen, Budding, Kevin, Van de Ven, Liesbeth, Dijkxhoorn, Kim, de Zeeuw, Elisabeth, Yildiz, Cafer, Gabriels, Sofie, Percier, Jean-Michel, Wildemann, Johanna, Meeldijk, Jan, Simons, Peter J., Boon, Louis, Cox, Linda, Holgate, Rob, Urbanus, Rolf, Otten, Henny G., Leusen, Jeanette H.W., Blanchetot, Christophe, de Haard, Hans, Hack, C. Erik, Boross, Peter

Volltext

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife von Zokaei, Nahid, Giehl, Kathrin, Sillence, Annie, Neville, Matt J., Karpe, Fredrik, Nobre, Anna C., Husain, Masud

Volltext

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B von Hulstein, Janine J.J., de Groot, Philip G., Silence, Karen, Veyradier, Agnès, Fijnheer, Rob, Lenting, Peter J.

Volltext

Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK von Lim, Jamie L, Augustinus, Roy, Plomp, Jaap J, Roya-Kouchaki, Kasra, Vergoossen, Dana L E, Fillié-Grijpma, Yvonne, Struijk, Josephine, Thomas, Rachel, Salvatori, Daniela, Steyaert, Christophe, Blanchetot, Christophe, Vanhauwaert, Roeland, Silence, Karen, van der Maarel, Silvère M, Verschuuren, Jan J, Huijbers, Maartje G

Volltext

CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants von Trebing, J, El-Mesery, M, Schäfer, V, Weisenberger, D, Siegmund, D, Silence, K, Wajant, H

Volltext

ARGX-117, a therapeutic complement inhibiting antibody targeting C2 von Van de Walle, Inge, Silence, Karen, Budding, Kevin, Van de Ven, Liesbeth, Dijkxhoorn, Kim, de Zeeuw, Elisabeth, Yildiz, Cafer, Gabriels, Sofie, Percier, Jean-Michel, Wildemann, Johanna, Meeldijk, Jan, Simons, Peter J, Boon, Louis, Cox, Linda, Holgate, Rob, Urbanus, Rolf, Otten, Henny G, Leusen, Jeanette H W, Blanchetot, Christophe, de Haard, Hans, Hack, C Erik, Boross, Peter

Volltext